Slow-paced respiration therapy to treat symptoms in pulmonary arterial hypertension.

ABSTRACT:

Objective

To determine the feasibility of using slow-paced respiration therapy to treat symptoms in women with pulmonary arterial hypertension (PAH).

Background

People with PAH report increased dyspnea, fatigue and sleep disturbance that can impair health-related quality of life (HRQOL).

Methods

Ten women with PAH received 8-weeks of daily, 15 min sessions using slow-paced respiration therapy via the RESPeRATE™ device. Participants had baseline and follow up assessments including plasma norepinephrine and interleukin-6 (IL-6), self-report questionnaires to measure dyspnea, fatigue, depressive symptoms, sleep and HRQOL along with 7-day actigraphy and sleep diaries.

Results

The mean age was 50 years. Adherence to the intervention was 92%. There was decrease in me

SUBMITTER: Matura LA 

PROVIDER: S-EPMC5167631 | biostudies-literature | 2017 Jan - Feb

REPOSITORIES: biostudies-literature